TermanDSImmunosorbents in autoimmune and neoplastic diseases. Plasma Ther Transfus Technol1983; 4:415–33.
3.
TermanDS, BuffaloeG, MattioliCExtracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus. Lancet1979; II: 824–7.
4.
BannetAD, BensingerWI, RajaR, BaqueroA, Mc AllackRF. Immunoadsorption and renal transplant in two patients with a major ABO incompatibility. Transplantation1987;43:909–11.
5.
BensingerWI. Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant. Artif Organs1981; 5:254–8.
6.
BensingerWI, BakerDA, BucknerCD, CliftRA, ThomasED. Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med1981; 304:160–2.
7.
OsterwalderB, GratwohlA, NissenC, SpeckB.Immunoadsorption for removal of anti-A and anti-B blood group antibodies in ABO-incompatible bone marrow transplantation. Blut1986; 53:379–90.
8.
BorbergH, BodeC, MatteleL, OetteK, TaucherM, StoffelW.LDL-apheresis in hypercholesterolemic patients: technical and clinical aspects. In: LysaghtJS, GurlandHJ, eds. Plasma separation and plasma fractionation.Basel: S Karger, 1983; 266–71.
9.
StoffelW, DemantT.Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma. Proc Nat Acad Sci USA1981; 78:611–5.
10.
StoffelW, BorbergH, GreeveV.Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet1981; 11:1005–7.
11.
StoffelW, BodeC.Selective removal of low density lipoproteins. In: PinedaAA, ed. Selective plasma component removal, Mount Kisco, New York: Futura Publ Co, 1984; 1–22.
12.
YamawakiN, FurutaT, YamagataJImprovement of plasma exchange for rheumatic disease: an adsorbent for rheumatoid factor and immune complexes in plasma. Artif Organs1981; 5, (Suppl.): 148–51.
NilssonIM, SundquistS-B, FreiburghausC.Extracorporeal protein A-sepharose and specific affinity chromatography for removal of antibodies. In: HoyerLW, ed. Factor VIII inhibitors — Progress in clinical and biological research”.Vol. 150. New York: Alan Liss Inc, 1984; 1–16.
15.
SatoH, KidakaT, HoriM.Selective removal of IgE in online plasmapheresis. Progr Artif Organs - 1983. Cleveland: ISAO Press, 1984; n. 204:703–7.
16.
TraegerJ, LavilleM, EI HabibR, MoskovtchenkoJF, CouletPR, GautheronDC. Extracorporeal immunoadsorption of DNA-antibodies on DNA-coated collagen films: first results in systemic lupus erythematosus. In: NoseY, MalcheskyPS, SmithJW, eds. Plasmapheresis: new trends in therapeutic applications.Cleveland: ISAO Press, 1983; 155–66.
17.
ForsgrenA, GhetieV, LindmarkR, SjöquistJ.Protein A and its exploitation. In: EasmonCSF, AdlamC, eds. Staphylococci and staphylococcal Infections, Vol. 2. London: Academic Press, 1983; 429–80.
18.
LangoneJJ. Protein A of staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumococci. Adv Immunol1982; 32:157–252.
19.
LangoneJJ. Applications of immobilized protein A in immunochemical techniques. J Immunol Methods1982; 55:277–96.
20.
RayPK. Extracorporeal adsorption of pathologic gammaglobulins and immune complexes in various diseases including cancer. Plasma Ther Transfus Technol1983; 4:289–300.
21.
NilssonIM, JonssonS, SundquistS-B, AhlbergA, BergentzSE. A procedure for removing high titer antibodies by extracorporeal protein A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies. Blood1981; 58:38–44.
22.
NilssonIM, SundquistS-B, LjungR, HolmbergL, FreiburghausC, BjörlinG.Suppression of secondary antibody response by intravenous immunoglobulin in a patient with hemophilia B and antibodies. Scand J Haematol1983; 30:458–64.
23.
YamazakiZ, FujimoriY, TakahamaTEfficiency and biocompatibility of a new immunosorbent. Trans Am Soc Artif Intern Organs1982; 28:318–23.
24.
YamazakiZ, lizukaI, KanaiF, Immunoadsorbent (IM-P) plasma perfusion in patients with rheumatoid arthritis or SLE. J Eur Soc Artif Organs1983; 1, Suppl. 1:98–101.
25.
SatoT, NishimiyaJ, ÁraiKSelective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunoadsorbent. In: OdaT, ed. Therapeutic plasmapheresis III, Stuttgart: Schattauer- Verlag, 1983; 565–8.
26.
AssmannG.Lipidstoffwechsel und Atherosklerose. Stuttgart-Verlag, 1982.
27.
SchaeferEJ, LevyRL. Pathogenesis and management of lipoprotein disorders. N Engl J Med1985; 312:1300–10.
28.
SchwerdtfegerR, von BaeyerH, KochinkeF.Substitution-free therapeutic plasmapheresis by selective protein ultrafiltration using a 0.6 mega dalton membrane. In: NoseY, MalcheskyPS, SmithJW, eds. Therapeutic apheresis: a critical look.Cleveland: ISAO Press, 1984; 236–40.
29.
AntwilerGD, DauPC, LobdellDD. Treatment of familial hypercholesterolemia by precipitation of low density lipoproteins with dextran sulfate. 1st World Apheresis Ass Congr.Tokyo, Japan, May 20–23, 1986 (abstract).
30.
EisenhauerT, ArmstrongVW, WielandH, FuchsC, SchelerF, SeidelD.Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wschr1987; 65:161–8.
31.
RiesenWF, ImhofC, SturzeneggerE, DescoeudresC, MordasiniR, OetlikerOH. Behandlung einer Hypercholesterinämie durch extrakorporale Immunadsorption. Schweiz Med Wschr1986; 116:8–11.
32.
SaalSD, ParkerTS, GordonBRRemoval of low-density lipoproteins in patients by extracorporeal immunoadsorption. Amer J Med1986; 80:583–9.
33.
KorenE, SolterD, LeeDM, Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies. Biochim Biophys Acta1986; 876:91–100.
34.
KorenE, Knight-GibsonC, WenG, De BaultLE, AlaupovicP.Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. II. Isolation of apolipoprotein B-containing lipoproteins from human plasma. Biochim Biophys Acta1986; 876:101–7.
35.
HommaY, MikamiY, TamachiH, NakayaN, NakamuraH, GotoY.Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia. Metabolism1987; 36:419–25.
36.
KurodaT, OkamotoT, YokoyamaTHigh capacity adsorbent of low density lipoprotein (LDL) from plasmapheresis. 1st World Apheresis Ass Congress. Tokyo, Japan, May 20–23, 1986, (abstract).
37.
LupienP-J, MoorjaniS, LouM, BrunD, GagneC.Removal of cholesterol from blood by affinity binding to heparin-agarose: evaluation on treatment in homozygous familial hypercholesterolemia. Pediat Res1980; 14:113–7.
38.
MaaskantN, BantjesA, KempenHJM. Removal of low density lipoprotein from blood plasma using cross-linked, sulfated polyvinylalcohol. Atherosclerosis1986; 62:159–66.
39.
OdakaM, KobayashiH, SoedaKLong term results of LDL selective plasma adsorption therapy on familial hypercholesterolemia. Biomat Artif Cells Artif Organs1987; 15:113–24.
40.
YokoyamaS, HayashiR, KikkawaTSpecific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits. Arteriosclerosis1984; 4:276–82.
41.
BehmE, LothF, ToeweD, ErnstB., KlinkmannH.Selektive Adsorbentien für Lipoproteine niederer Dichte (LDL): in vitro-Studien. Ztschr Klin Med1988; 43:121–4.
42.
BehmE, KurodaT, YamawakiNIn vitro investigations with selective adsorbents for IgE and IgM. Biomat Artif Cells Artif Organs1987; 15:101–11.
43.
BehmE, ZinnerG, RichersASelektive Bindung immunologisch relevanter Moleküle: in vitro-Studien mit verschiedenen Adsorbentien unter dem Aspekt ihrer klinischen Anwendung. Ztschr Klin Med1988; 43:295–8.
44.
BehmE, KlinkmannH.Immunoadsorption for clinical application — in vitro studies with protein A-carrying staphylococci. In: LysaghtMJ, GurlandHJ, eds. Plasma separation and plasma fractionation, S Karger. Basel: 1983; 254–65.